Prot #OER-SAR-043: NU FC11S02: Phase II Study Evaluating the Role of Pazopanib in Angiosarcoma

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/30/12 → 11/30/18

Funding

  • Fox Chase Network, Inc. (Prot #OER-SAR-043)
  • GlaxoSmithKline LLC (Prot #OER-SAR-043)